Mutations in histone modulators are associated with prolonged survival during azacitidine therapy.
Tobiasson M, McLornan DP, Karimi M, Dimitriou M, Jansson M, Ben Azenkoud A, Jädersten M, Lindberg G, Abdulkadir H, Kulasekararaj A, Ungerstedt J, Lennartsson A, Ekwall K, Mufti GJ, Hellström-Lindberg E.
Tobiasson M, et al.
Oncotarget. 2016 Apr 19;7(16):22103-15. doi: 10.18632/oncotarget.7899.
Oncotarget. 2016.
PMID: 26959885
Free PMC article.